Briefing: Doctors Without Borders calls Gilead ‘unconscionable’ for refusing to sell HIV prevention drug
Strategic angle: The organization criticized Gilead Sciences after months of negotiations for a limited supply of lenacapavir.
Editorial Staff
1 min read
Updated 4 months ago
Doctors Without Borders sought lenacapavir for HIV prevention.
Gilead Sciences declined the request after extended discussions.
The refusal has sparked significant backlash from health advocates.